Logo image of ZDAI

PRIMEGA GROUP HOLDINGS LTD (ZDAI) Stock Fundamental Analysis

NASDAQ:ZDAI - Nasdaq - KYG7241B1106 - Common Stock - Currency: USD

0.5202  -0.02 (-3.84%)

Fundamental Rating

4

ZDAI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Ground Transportation industry. While ZDAI has a great health rating, its profitability is only average at the moment. ZDAI has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ZDAI was profitable.
ZDAI had a positive operating cash flow in the past year.
ZDAI Yearly Net Income VS EBIT VS OCF VS FCFZDAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 500K 1M 1.5M 2M

1.2 Ratios

The Return On Assets of ZDAI (12.55%) is better than 92.50% of its industry peers.
The Return On Equity of ZDAI (39.11%) is better than 95.00% of its industry peers.
ZDAI's Return On Invested Capital of 22.61% is amongst the best of the industry. ZDAI outperforms 95.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZDAI is significantly above the industry average of 8.54%.
The last Return On Invested Capital (22.61%) for ZDAI is well below the 3 year average (27.06%), which needs to be investigated, but indicates that ZDAI had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.55%
ROE 39.11%
ROIC 22.61%
ROA(3y)15.72%
ROA(5y)N/A
ROE(3y)53.36%
ROE(5y)N/A
ROIC(3y)27.06%
ROIC(5y)N/A
ZDAI Yearly ROA, ROE, ROICZDAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 20 40 60 80

1.3 Margins

The Profit Margin of ZDAI (8.68%) is better than 75.00% of its industry peers.
ZDAI has a Operating Margin of 11.08%. This is in the better half of the industry: ZDAI outperforms 75.00% of its industry peers.
ZDAI's Gross Margin of 21.45% is on the low side compared to the rest of the industry. ZDAI is outperformed by 67.50% of its industry peers.
Industry RankSector Rank
OM 11.08%
PM (TTM) 8.68%
GM 21.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZDAI Yearly Profit, Operating, Gross MarginsZDAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 5 10 15 20 25

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so ZDAI is creating value.
The number of shares outstanding for ZDAI has been reduced compared to 1 year ago.
ZDAI has a better debt/assets ratio than last year.
ZDAI Yearly Shares OutstandingZDAI Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
ZDAI Yearly Total Debt VS Total AssetsZDAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

An Altman-Z score of 3.53 indicates that ZDAI is not in any danger for bankruptcy at the moment.
The Altman-Z score of ZDAI (3.53) is better than 75.00% of its industry peers.
ZDAI has a debt to FCF ratio of 1.85. This is a very positive value and a sign of high solvency as it would only need 1.85 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.85, ZDAI belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
A Debt/Equity ratio of 0.73 indicates that ZDAI is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.73, ZDAI is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
Although ZDAI does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 1.85
Altman-Z 3.53
ROIC/WACC2.58
WACC8.75%
ZDAI Yearly LT Debt VS Equity VS FCFZDAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 1M 2M 3M 4M

2.3 Liquidity

A Current Ratio of 1.41 indicates that ZDAI should not have too much problems paying its short term obligations.
The Current ratio of ZDAI (1.41) is better than 70.00% of its industry peers.
ZDAI has a Quick Ratio of 1.41. This is a normal value and indicates that ZDAI is financially healthy and should not expect problems in meeting its short term obligations.
ZDAI has a Quick ratio of 1.41. This is in the better half of the industry: ZDAI outperforms 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.41
ZDAI Yearly Current Assets VS Current LiabilitesZDAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2M 4M 6M

1

3. Growth

3.1 Past

The earnings per share for ZDAI have decreased by -0.21% in the last year.
ZDAI shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.83%.
EPS 1Y (TTM)-0.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.26%
Revenue 1Y (TTM)20.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%63.05%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZDAI Yearly Revenue VS EstimatesZDAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2M 4M 6M 8M 10M

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 8.67 indicates a reasonable valuation of ZDAI.
Compared to the rest of the industry, the Price/Earnings ratio of ZDAI indicates a rather cheap valuation: ZDAI is cheaper than 95.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ZDAI to the average of the S&P500 Index (26.48), we can say ZDAI is valued rather cheaply.
Industry RankSector Rank
PE 8.67
Fwd PE N/A
ZDAI Price Earnings VS Forward Price EarningsZDAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ZDAI is valued cheaply inside the industry as 92.50% of the companies are valued more expensively.
100.00% of the companies in the same industry are more expensive than ZDAI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.74
EV/EBITDA 4.91
ZDAI Per share dataZDAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ZDAI!.
Industry RankSector Rank
Dividend Yield N/A

PRIMEGA GROUP HOLDINGS LTD

NASDAQ:ZDAI (8/8/2025, 8:13:23 PM)

0.5202

-0.02 (-3.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.95%
Inst Owner ChangeN/A
Ins Owners67.58%
Ins Owner ChangeN/A
Market Cap13.73M
AnalystsN/A
Price TargetN/A
Short Float %4.78%
Short Ratio6.92
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 8.67
Fwd PE N/A
P/S 0.71
P/FCF 5.74
P/OCF 5.74
P/B 3.2
P/tB 3.2
EV/EBITDA 4.91
EPS(TTM)0.06
EY11.53%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.09
FCFY17.43%
OCF(TTM)0.09
OCFY17.43%
SpS0.73
BVpS0.16
TBVpS0.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.55%
ROE 39.11%
ROCE 27.29%
ROIC 22.61%
ROICexc 24.12%
ROICexgc 24.12%
OM 11.08%
PM (TTM) 8.68%
GM 21.45%
FCFM 12.38%
ROA(3y)15.72%
ROA(5y)N/A
ROE(3y)53.36%
ROE(5y)N/A
ROIC(3y)27.06%
ROIC(5y)N/A
ROICexc(3y)28.14%
ROICexc(5y)N/A
ROICexgc(3y)28.14%
ROICexgc(5y)N/A
ROCE(3y)32.66%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.45
Health
Industry RankSector Rank
Debt/Equity 0.73
Debt/FCF 1.85
Debt/EBITDA 0.87
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage 10.17
Cash Conversion 66.53%
Profit Quality 142.72%
Current Ratio 1.41
Quick Ratio 1.41
Altman-Z 3.53
F-Score8
WACC8.75%
ROIC/WACC2.58
Cap/Depr(3y)32.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.87%
Cap/Sales(5y)N/A
Profit Quality(3y)119.51%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-44.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.83%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%63.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.77%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y201.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y185.02%
OCF growth 3YN/A
OCF growth 5YN/A